Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
ACADIA Pharmaceuticals has a twelve month low of $13.73 and a twelve month high of $32.89.
Envestnet Asset Management Inc.’s holdings in ACADIA Pharmaceuticals were worth $867,000 at the end of the most recent quarter.
Guggenheim increased their target price on shares of ACADIA Pharmaceuticals from $22.00 to $25.00 in a research note on Tuesday, March 14th.
HighTower Advisors LLC bought a new position in ACADIA Pharmaceuticals during the 1st quarter worth about $1,077,000.
JMP Securities boosted their price objective on ACADIA Pharmaceuticals from $31.00 to $39.00 and gave the stock a market outperform rating in a research note on Friday.
JMP Securities dropped their target price on shares of ACADIA Pharmaceuticals from $24.00 to $22.00 and set a “market perform” rating on the stock in a report on Tuesday, February 28th.
Royal Bank of Canada lifted their price objective on shares of ACADIA Pharmaceuticals from $19.00 to $27.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 28th.
State of New Jersey Common Pension Fund D grew its position in shares of ACADIA Pharmaceuticals by 6.9% during the 4th quarter.